Non-Current Assets
Capitalized Contract Costs, Net
Idexx Laboratories Capitalized Contract Costs, Net decreased by 0.5% to $21.3M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.6%, from $22.8M to $21.3M. Over 5 years (FY 2020 to FY 2025), Capitalized Contract Costs, Net shows an upward trend with a 4.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ3 2018
Last reportedQ1 2026May 5, 2026
Metric ID:
capitalized_contract_costs_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.4M | $19M | $19.5M | $19.4M | $19.3M | $19M | $19.2M | $19.3M | $19.5M | $19.2M | $19.7M | $19.7M | $19.6M | $20.6M | $22M | $22.8M | $21.5M | $21.5M | $21.4M | $21.3M |
| QoQ Change | — | +3.3% | +2.6% | -0.5% | -0.5% | -1.6% | +1.1% | +0.5% | +1.0% | -1.5% | +2.6% | +0.0% | -0.5% | +5.1% | +6.8% | +3.6% | -5.7% | +0.0% | -0.5% | -0.5% |
| YoY Change | — | — | — | — | +4.9% | +0.0% | -1.5% | -0.5% | +1.0% | +1.1% | +2.6% | +2.1% | +0.5% | +7.3% | +11.7% | +15.7% | +9.7% | +4.4% | -2.7% | -6.6% |
Range$18.4M – $22.8M
CAGR+3.1%
Avg YoY Growth+3.1%
Median YoY Growth+1.6%
Current Streak2 quarters decline
Product Breakdown
| Segment | Q4 '25 |
|---|---|
| Customer commitment arrangements, multi-year arrangements | $250.1M |
| Total | $21.4M |
Capitalized Contract Costs, Net at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's capitalized contract costs, net?
- Idexx Laboratories (IDXX) reported capitalized contract costs, net of $21.3M in Q1 2026.
- How has Idexx Laboratories's capitalized contract costs, net changed year-over-year?
- Idexx Laboratories's capitalized contract costs, net decreased by 6.6% year-over-year, from $22.8M to $21.3M.
- What is the long-term trend for Idexx Laboratories's capitalized contract costs, net?
- Over 5 years (2020 to 2025), Idexx Laboratories's capitalized contract costs, net has grown at a 4.1% compound annual growth rate (CAGR), from $17.5M to $21.4M.